UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 19, 2016

AURORA DIAGNOSTICS HOLDINGS, LLC

(Exact name of registrant as specified in charter)


Delaware	333-176790	20-4918072

(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

11025 RCA Center Drive, Suite 300, Palm Beach Gardens, Florida 33410

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (866) 420-5512

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The terms of the Company’s Second Amended and Restated Limited Liability Company Agreement provide for the designation of up to three of the Company’s managers by KRG Capital Partners, one of the Company’s principal equityholders. Mr. Blair Tikker, one of KRG Capital Partners’ designees, notified the Company of his resignation as a member of the Company’s Board of Managers effective on December 19, 2016, in connection with his resignation from KRG Capital effective December 31, 2016. At this time, a replacement member has not been appointed to fill the vacancy created by Mr. Tikker’s resignation.

For information regarding related party transactions between the Company and KRG Capital Partners, see the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	Aurora Diagnostics Holdings, LLC
December 21, 2016	/s/ Michael C. Grattendick
	Michael C. Grattendick
	Chief Financial Officer

AURORA DIAGNOSTICS HOLDINGS LLC 8-K